Editorial: Difficult and severe asthma in children, volume II.
作者信息
Ullmann Nicola, Bush Andrew, Piacentini Giorgio, Santamaria Francesca, Cutrera Renato
机构信息
Pneumology and Cystic Fibrosis Unit, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, Rome, Italy.
Professor of Paediatrics, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
出版信息
Front Pediatr. 2023 Mar 16;11:1158309. doi: 10.3389/fped.2023.1158309. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Difficult and severe asthma in children, volume II.社论：儿童重度和难治性哮喘，第二卷。
Front Pediatr. 2023 Mar 16;11:1158309. doi: 10.3389/fped.2023.1158309. eCollection 2023.
2
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.生物制剂（贝那利珠单抗、度普利尤单抗、美泊利单抗、奥马珠单抗和瑞利珠单抗）治疗重度嗜酸性粒细胞性哮喘的疗效和安全性。EAACI指南的系统评价——关于生物制剂在重度哮喘中应用的建议
Allergy. 2020 May;75(5):1023-1042. doi: 10.1111/all.14221. Epub 2020 Feb 24.
3
Cost-effectiveness analysis of dupilumab among patients with oral corticosteroid-dependent uncontrolled severe asthma in Japan.度普利尤单抗在日本口服糖皮质激素依赖且控制不佳的重度哮喘患者中的成本效益分析。
J Asthma. 2022 Nov;59(11):2162-2173. doi: 10.1080/02770903.2021.1996596. Epub 2021 Dec 8.
4
Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment.美泊利珠单抗治疗既往使用奥马珠单抗治疗的重度嗜酸性粒细胞性哮喘患者的疗效
Allergy. 2016 Sep;71(9):1335-44. doi: 10.1111/all.12914. Epub 2016 May 24.
5
Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma.在未控制的持续性哮喘患者中，度普利尤单抗与其他生物制剂的两两间接治疗比较。
Respir Med. 2022 Jan;191:105991. doi: 10.1016/j.rmed.2020.105991. Epub 2020 Apr 29.
6
Comparative effectiveness of mepolizumab and omalizumab in severe asthma: An indirect treatment comparison.美泊利珠单抗和奥马珠单抗治疗重度哮喘的比较疗效：间接治疗比较
Respir Med. 2017 Feb;123:140-148. doi: 10.1016/j.rmed.2016.12.009. Epub 2016 Dec 21.
7
Upper and lower airway inflammation in severe asthmatics: a guide for a precision biologic treatment.严重哮喘患者的上下气道炎症：精准生物治疗的指导。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620965151. doi: 10.1177/1753466620965151.
8
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy.从奥马珠单抗转换为美泊利珠单抗：来自意大利南部的真实临床经验。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620929231. doi: 10.1177/1753466620929231.
9
Dupilumab for the treatment of asthma.度普利尤单抗用于治疗哮喘。
Expert Opin Investig Drugs. 2017 Mar;26(3):357-366. doi: 10.1080/13543784.2017.1282458. Epub 2017 Feb 7.
10
Real-world Omalizumab and Mepolizumab treated difficult asthma phenotypes and their clinical outcomes.真实世界中奥马珠单抗和美泊利单抗治疗的难治性哮喘表型及其临床结局。
Clin Exp Allergy. 2021 Aug;51(8):1019-1032. doi: 10.1111/cea.13882. Epub 2021 May 6.
本文引用的文献
1
Early-life risk factors for development of asthma from 8 to 28 years of age: a prospective cohort study.8至28岁哮喘发病的早期生活危险因素：一项前瞻性队列研究。
ERJ Open Res. 2022 Dec 12;8(4). doi: 10.1183/23120541.00074-2022. eCollection 2022 Oct.
2
Asthma Management in Children.儿童哮喘管理
J Allergy Clin Immunol Pract. 2023 Jan;11(1):9-18. doi: 10.1016/j.jaip.2022.10.031. Epub 2022 Nov 9.
3
Difficult and Severe Asthma in Children.儿童重度和极重度哮喘
Children (Basel). 2020 Dec 10;7(12):286. doi: 10.3390/children7120286.
4
This Child's Asthma Appears to Be Severe: But Where Actually Is the Severe Problem?这个孩子的哮喘似乎很严重：但问题到底出在哪里呢？
Acta Med Acad. 2020 Aug;49(2):103-116. doi: 10.5644/ama2006-124.290.
5
Primary prevention of asthma: from risk and protective factors to targeted strategies for prevention.哮喘的一级预防：从风险和保护因素到有针对性的预防策略。
Lancet. 2020 Sep 19;396(10254):854-866. doi: 10.1016/S0140-6736(20)31861-4. Epub 2020 Sep 7.
6
Genetics and Gene-Environment Interactions in Childhood and Adult Onset Asthma.儿童期和成人期哮喘的遗传学及基因-环境相互作用
Front Pediatr. 2019 Dec 11;7:499. doi: 10.3389/fped.2019.00499. eCollection 2019.
7
Transition for Adolescents and Young Adults With Asthma.哮喘青少年和青年的过渡
Front Pediatr. 2019 Jul 23;7:301. doi: 10.3389/fped.2019.00301. eCollection 2019.
8
Editorial: Difficult and Severe Asthma in Children.社论：儿童重度和难治性哮喘
Front Pediatr. 2019 May 17;7:205. doi: 10.3389/fped.2019.00205. eCollection 2019.
9
Asthma: Differential Diagnosis and Comorbidities.哮喘：鉴别诊断与共病
Front Pediatr. 2018 Oct 3;6:276. doi: 10.3389/fped.2018.00276. eCollection 2018.
10
Prenatal vitamin D supplementation reduces risk of asthma/recurrent wheeze in early childhood: A combined analysis of two randomized controlled trials.产前补充维生素D可降低幼儿患哮喘/复发性喘息的风险：两项随机对照试验的综合分析。
PLoS One. 2017 Oct 27;12(10):e0186657. doi: 10.1371/journal.pone.0186657. eCollection 2017.
Zotero 插件